SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-3.48 Cr | ₹27 Cr | ₹41 Cr | ₹55 Cr | ₹32 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAKAR HEALTHCARE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-3.48 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹32 Cr |
How is Cash Flow from Financing Activities of SAKAR HEALTHCARE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3.48 Cr | Negative | |
| Mar2024 | ₹27 Cr | -33.22 | |
| Mar2023 | ₹41 Cr | -24.76 | |
| Mar2022 | ₹55 Cr | 70.51 | |
| Mar2021 | ₹32 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹833.2 Cr | 3.9% | 3.3% | 25.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 3.9% |
3.3% |
25.1% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses